4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

EPMA J · 2014 · PMC4417534 · PMID 25937854

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

It showed that vitamin E was superior to placebo and suggested that pioglitazone may also have efficacy with highly significant reductions in steatosis, inflammation and hepatocellular ballooning, as well as with improvements in IR and liver-enzyme levels.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.